-
1
-
-
0442268112
-
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
-
AIDS Clinical Trials Group 320 Study Team
-
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-33.
-
(1997)
N Engl J Med
, vol.337
, pp. 725-733
-
-
Hammer, S.M.1
Squires, K.E.2
Hughes, M.D.3
-
2
-
-
0033576816
-
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
-
Study 006 Team
-
Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999;341:1865-73.
-
(1999)
N Engl J Med
, vol.341
, pp. 1865-1873
-
-
Staszewski, S.1
Morales-Ramirez, J.2
Tashima, K.T.3
-
3
-
-
76649092701
-
-
UNAIDS. Report on the Global AIDS epidemic, http://www.unaids.org/en/ knowledge/HIVdata/globalreport/2008/2008-global-report.asp, 2008.
-
(2008)
Report on the Global AIDS Epidemic
-
-
-
4
-
-
43049128496
-
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
-
Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008;371:1603-11.
-
(2008)
Lancet
, vol.371
, pp. 1603-1611
-
-
Jahn, A.1
Floyd, S.2
Crampin, A.C.3
-
5
-
-
64349118898
-
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies
-
When To Start Consortium
-
When To Start Consortium, Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;373:1352-63.
-
(2009)
Lancet
, vol.373
, pp. 1352-1363
-
-
Sterne, J.A.1
May, M.2
Costagliola, D.3
-
6
-
-
33746512140
-
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
-
DOI 10.1016/S0140-6736(06)69162-9, PII S0140673606691629
-
Montaner JS, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006;368:531-6. (Pubitemid 44142776)
-
(2006)
Lancet
, vol.368
, Issue.9534
, pp. 531-536
-
-
Montaner, J.S.1
Hogg, R.2
Wood, E.3
Kerr, T.4
Tyndall, M.5
Levy, A.R.6
Harrigan, P.R.7
-
7
-
-
58149097694
-
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model
-
Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009;373:48-57.
-
(2009)
Lancet
, vol.373
, pp. 48-57
-
-
Granich, R.M.1
Gilks, C.F.2
Dye, C.3
-
8
-
-
0034732201
-
Viral load and heterosexual transmission of human immunodeficiency virus type 1
-
Rakai Project Study Group
-
Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9.
-
(2000)
N Engl J Med
, vol.342
, pp. 921-929
-
-
Quinn, T.C.1
Wawer, M.J.2
Sewankambo, N.3
-
9
-
-
47049122773
-
Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
-
Vernazza P, Hirschel B, Bernasconi E, et al. Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des médecins suisses 2008;89:165-9.
-
(2008)
Bulletin des Médecins Suisses
, vol.89
, pp. 165-169
-
-
Vernazza, P.1
Hirschel, B.2
Bernasconi, E.3
-
10
-
-
67149086831
-
The debate continues: Does 'undetectable' mean 'uninfectious'?
-
Vernazza PL. The debate continues: does 'undetectable' mean 'uninfectious'? HIV ther 2009;3:113-16.
-
(2009)
HIV Ther
, vol.3
, pp. 113-116
-
-
Vernazza, P.L.1
-
11
-
-
78751659719
-
AIDS 2008: The Swiss Statement- The debate continues
-
Available at accessed 29 June 2010
-
National Association of People Living With HIV/AIDS 2008. AIDS 2008: The Swiss Statement- the debate continues, 2009. Available at http://napwa.org.au/ pl/2008/09/aids-2008-the-swiss-statement-the-debate-continues (accessed 29 June 2010).
-
(2009)
National Association of People Living with HIV/AIDS 2008
-
-
-
12
-
-
49949104062
-
Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?
-
Sturmer M, Doerr HW, Berger A, et al. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther 2008;13:729-32.
-
(2008)
Antivir Ther
, vol.13
, pp. 729-732
-
-
Sturmer, M.1
Doerr, H.W.2
Berger, A.3
-
13
-
-
47649111041
-
Relation between HIV viral load and infectiousness: A model-based analysis
-
Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008;372:314-20.
-
(2008)
Lancet
, vol.372
, pp. 314-320
-
-
Wilson, D.P.1
Law, M.G.2
Grulich, A.E.3
-
14
-
-
47649124453
-
Risk of HIV transmission in discordant couples
-
Garnett GP, Gazzard B. Risk of HIV transmission in discordant couples. Lancet 2008;372:270-1.
-
(2008)
Lancet
, vol.372
, pp. 270-271
-
-
Garnett, G.P.1
Gazzard, B.2
-
15
-
-
68449085124
-
Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis
-
Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. Aids 2009;23:1397-404.
-
(2009)
Aids
, vol.23
, pp. 1397-1404
-
-
Attia, S.1
Egger, M.2
Muller, M.3
-
16
-
-
68449090720
-
Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy
-
Wilson DP. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. Aids 2009;23:1431-3.
-
(2009)
Aids
, vol.23
, pp. 1431-1433
-
-
Wilson, D.P.1
-
17
-
-
0242301662
-
Mortality and progression to AIDS after starting highly active antiretroviral therapy
-
van Sighem AI, van de Wiel MA, Ghani AC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. Aids 2003;17:2227-36.
-
(2003)
Aids
, vol.17
, pp. 2227-2236
-
-
Van Sighem, A.I.1
Van De Wiel, M.A.2
Ghani, A.C.3
-
18
-
-
41549159352
-
The impact of monitoring HIV patients prior to treatment in resource-poor settings: Insights from mathematical modelling
-
Hallett TB, Gregson S, Dube S, et al. The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med 2008;5:e53.
-
(2008)
PLoS Med
, vol.5
-
-
Hallett, T.B.1
Gregson, S.2
Dube, S.3
-
19
-
-
44849110373
-
Late entry to HIV care limits the impact of antiretroviral therapy in the Netherlands
-
Smit C, Hallett TB, Lange J, et al. Late entry to HIV care limits the impact of antiretroviral therapy in The Netherlands. PLoS One 2008;3:e1949.
-
(2008)
PLoS One
, vol.3
-
-
Smit, C.1
Hallett, T.B.2
Lange, J.3
-
20
-
-
36849064140
-
Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
-
Fraser C, Hollingsworth TD, Chapman R, et al. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A 2007;104:17441-6.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 17441-17446
-
-
Fraser, C.1
Hollingsworth, T.D.2
Chapman, R.3
-
21
-
-
23244439755
-
Estimating the proportion of patients infected with HIV who will die of comorbid diseases
-
Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med 2005;118:890-8.
-
(2005)
Am J Med
, vol.118
, pp. 890-898
-
-
Braithwaite, R.S.1
Justice, A.C.2
Chang, C.C.3
-
22
-
-
78751661822
-
-
Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/, 2008.
-
(2008)
-
-
-
23
-
-
69449093803
-
Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up
-
Ndiaye B, Ould-Kaci K, Salleron J, et al. Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. AIDS 2009;23:1786-9.
-
(2009)
AIDS
, vol.23
, pp. 1786-1789
-
-
Ndiaye, B.1
Ould-Kaci, K.2
Salleron, J.3
-
24
-
-
4744352699
-
Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men
-
Stolte IG, de Wit JB, van EA, et al. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV-infected homosexual men. AIDS 2004;18:1943-9.
-
(2004)
AIDS
, vol.18
, pp. 1943-1949
-
-
Stolte, I.G.1
De Wit, J.B.2
Van, E.A.3
-
26
-
-
0033178369
-
Per-contact risk of human immunodeficiency virus transmission between male sexual partners
-
Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150:306-11.
-
(1999)
Am J Epidemiol
, vol.150
, pp. 306-311
-
-
Vittinghoff, E.1
Douglas, J.2
Judson, F.3
-
27
-
-
33745115034
-
Risk factors for HIV infection among men who have sex with men
-
Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids 2006;20:731-9.
-
(2006)
Aids
, vol.20
, pp. 731-739
-
-
Koblin, B.A.1
Husnik, M.J.2
Colfax, G.3
-
28
-
-
39149108828
-
Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia
-
Podsadecki TJ, Vrijens BC, Tousset EP, et al. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. J Infect Dis 2007;196:1773-8.
-
(2007)
J Infect Dis
, vol.196
, pp. 1773-1778
-
-
Podsadecki, T.J.1
Vrijens, B.C.2
Tousset, E.P.3
|